These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23359823)

  • 1. Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations.
    Gao X; Huang M; Liu L; He Y; Yu Q; Zhao H; Zhou C; Zhang J; Zhu Z; Wan J; Jiang X; Gao Y
    PLoS One; 2013; 8(1):e55169. PubMed ID: 23359823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma.
    Wang C; Zhao H; Zhao X; Wan J; Wang D; Bi W; Jiang X; Gao Y
    Tumour Biol; 2014 Jan; 35(1):295-301. PubMed ID: 23918301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional insertion/deletion polymorphism in the promoter of PDCD6IP is associated with the susceptibility of hepatocellular carcinoma in a Chinese population.
    Yu Q; Zhou C; Wang J; Chen L; Zheng S; Zhang J
    DNA Cell Biol; 2013 Aug; 32(8):451-7. PubMed ID: 23777424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An indel polymorphism in the 3' untranslated region of HMGB1 confers risk for hepatocellular carcinoma by regulating HMGB1 transcriptional activity in a Chinese population.
    Wang J; Zhu J; Mao DH; Zhu S; Mi XG; Yu Q
    Neoplasma; 2020 Jan; 67(1):61-67. PubMed ID: 31777261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma.
    Pasic I; Wong KM; Lee JJ; Espin-Garcia O; Brhane Y; Cheng D; Chen Z; Patel D; Brown C; Bucur R; Reisman D; Knox JJ; Xu W; Hung RJ; Liu G; Cleary SP
    Mol Carcinog; 2018 Jan; 57(1):106-113. PubMed ID: 28892201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 40-bp insertion/deletion polymorphism in the constitutive promoter of MDM2 confers risk for hepatocellular carcinoma in a Chinese population.
    Dong D; Gao X; Zhu Z; Yu Q; Bian S; Gao Y
    Gene; 2012 Apr; 497(1):66-70. PubMed ID: 22285926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
    Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
    Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA-G 3' UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population.
    Jiang Y; Chen S; Jia S; Zhu Z; Gao X; Dong D; Gao Y
    DNA Cell Biol; 2011 Dec; 30(12):1027-32. PubMed ID: 21612396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An insertion/deletion polymorphism in the 3' untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese.
    Chen S; He Y; Ding J; Jiang Y; Jia S; Xia W; Zhao J; Lu M; Gu Z; Gao Y
    Biochem Biophys Res Commun; 2010 Jan; 391(1):552-6. PubMed ID: 19931512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk.
    Liu G; Gramling S; Munoz D; Cheng D; Azad AK; Mirshams M; Chen Z; Xu W; Roberts H; Shepherd FA; Tsao MS; Reisman D
    Oncogene; 2011 Jul; 30(29):3295-304. PubMed ID: 21478907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.
    Liu F; Li F; Luo L; Yang H; Wei Y; Wang W; Yan L; Wen T; Yang J; Li B
    Apoptosis; 2017 Aug; 22(8):1035-1047. PubMed ID: 28643196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional insertion/deletion polymorphism in the proximal promoter of CD3G is associated with susceptibility for hepatocellular carcinoma in Chinese population.
    Jiang L; Xu J; Ni J; Gao X; Zhu Z; Dong D; Wang X; Shi C; Tao X; Dong W; Gao Y
    DNA Cell Biol; 2012 Sep; 31(9):1480-5. PubMed ID: 22731821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
    Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W
    Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of PTEN polymorphisms with susceptibility to hepatocellular carcinoma in a Han Chinese population.
    Ding J; Gao Y; Liu R; Xu F; Liu H
    DNA Cell Biol; 2011 Apr; 30(4):229-34. PubMed ID: 21138334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insertion/deletion polymorphism in the 3' untranslated region of type I collagen a2 (COL1A2) is associated with susceptibility for hepatocellular carcinoma in a Chinese population.
    Zhu Z; Jiang Y; Chen S; Jia S; Gao X; Dong D; Gao Y
    Cancer Genet; 2011 May; 204(5):265-9. PubMed ID: 21665180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.
    Li P; Gu J; Yang X; Cai H; Tao J; Yang X; Lu Q; Wang Z; Yin C; Gu M
    PLoS One; 2013; 8(8):e71604. PubMed ID: 23977085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
    Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
    Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of NFKB1 and NFKBIA gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathological features.
    Cheng CW; Su JL; Lin CW; Su CW; Shih CH; Yang SF; Chien MH
    PLoS One; 2013; 8(2):e56130. PubMed ID: 23457512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
    Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
    Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancers.
    Wong KM; Qiu X; Cheng D; Azad AK; Habbous S; Palepu P; Mirshams M; Patel D; Chen Z; Roberts H; Knox J; Marquez S; Wong R; Darling G; Waldron J; Goldstein D; Leighl N; Shepherd FA; Tsao M; Der S; Reisman D; Liu G
    Cancer Med; 2014 Apr; 3(2):426-33. PubMed ID: 24519853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.